anti-TDP-43 antibody-degron fusion protein VecTron (VectorY)

N/A

Report date: 2025/01/26 18:26:32

Base Information

Drug Nameanti-TDP-43 antibody-degron fusion protein VecTron (VectorY)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionTAR DNA binding protein 43 inhibitors
TargetsTAR DNA binding protein 43
Therapy Area/IndicationsNerve DegenerationAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVectorY BV
China Registration ClassN/A

Develop Information

Active CompaniesVectorY BV
Inactive CompaniesN/A
Active IndicationsNerve DegenerationAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A